ArticleMolecular therapy. Oncology2026

Oncolytic adenovirus incorporating TetO sites in the E1A promoter for controlled replication in TetR-expressing mesenchymal stem cells.

Ramon Alemany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.